We are live on
!
Find out more
Luther King Capital Management (LKCM) Portfolio holdings
AUM
$24.4B
1-Year Est. Return
22.19%
This Fund
S&P 500
This Quarter
Est. Return
-2.88%
1 Year Est. Return
+22.19%
3 Year Est. Return
+74.81%
5 Year Est. Return
+96.49%
10 Year Est. Return
+450.05%
AUM
$19.3B
AUM Growth
-$864M
(-4.3%)
Cap. Flow
-$44M
Cap. Flow
% of AUM
-0.23%
Top 10 Holdings %
Top 10 Hldgs %
30.78%
Holding
614
New
17
Increased
176
Reduced
219
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Albemarle
ALB
|
+$57.3M |
| 2 |
Eli Lilly
LLY
|
+$20.1M |
| 3 |
Teledyne Technologies
TDY
|
+$17.1M |
| 4 |
Fluor
FLR
|
+$11.6M |
| 5 |
GTLS
Chart Industries
GTLS
|
+$11.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FMC
FMC
|
+$58M |
| 2 |
US Bancorp
USB
|
+$21.1M |
| 3 |
Walt Disney
DIS
|
+$13.6M |
| 4 |
Keurig Dr Pepper
KDP
|
+$12.6M |
| 5 |
Estee Lauder
EL
|
+$11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.51% |
| 2 | Industrials | 18.88% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 8.62% |
| 5 | Consumer Discretionary | 7.16% |
Similar funds
JG
OAG
Luther King Capital Management (LKCM)'s Q3 2023 Portfolio in Review
As of Q3 2023, Luther King Capital Management (LKCM) held 614 positions worth $19.3B, down 4.3% from $20.1B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Luther King Capital Management (LKCM)'s Q3 2023 filing shows 17 new, 176 increased, 219 reduced and 27 closed positions. Its largest new stake was Fluor: 345,940 shares worth $12.7M. The largest sale was FMC, an estimated $58M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.
- Luther King Capital Management (LKCM)'s largest Q3 2023 buy was Fluor: 345,940 shares worth $12.7M.
- Luther King Capital Management (LKCM) added most to Albemarle in Q3 2023, an estimated $57.3M increase.
- Luther King Capital Management (LKCM)'s biggest Q3 2023 reduction was FMC, cutting an estimated $58M.
- Luther King Capital Management (LKCM) fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $6.68M.
- Luther King Capital Management (LKCM)'s ten largest holdings make up 31% of its $19.3B portfolio in Q3 2023.
- Luther King Capital Management (LKCM) opened 17 new positions and closed 27 in Q3 2023.
- Luther King Capital Management (LKCM)'s portfolio value fell 4.3% quarter-over-quarter to $19.3B.
Based on Luther King Capital Management (LKCM)'s 13F filing for Q3 2023, filed 13 Nov 2023.